Guardion Health Sciences (GHSI) stock price, revenue, and financials

Guardion Health Sciences market cap is $25.4 m, and annual revenue was $942.15 k in FY 2018

$25.4 M

GHSI Mkt cap, 13-Mar-2020

$161.2 K

Guardion Health Sciences Revenue Q3, 2019
Guardion Health Sciences Gross profit (Q3, 2019)90.2 K
Guardion Health Sciences Gross profit margin (Q3, 2019), %55.9%
Guardion Health Sciences Net income (Q3, 2019)-2.4 M
Guardion Health Sciences EBIT (Q3, 2019)-2.4 M
Guardion Health Sciences Cash, 30-Sept-20195.6 M
Guardion Health Sciences EV20.3 M

Guardion Health Sciences Revenue

Guardion Health Sciences revenue was $942.15 k in FY, 2018

Embed Graph

Guardion Health Sciences Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018

Revenue

141.0k437.3k942.2k

Cost of goods sold

75.7k175.5k398.2k

Gross profit

65.3k261.9k544.0k

Gross profit Margin, %

46%60%58%

Sales and marketing expense

389.1k599.9k1.5m

R&D expense

64.0k259.5k231.8k

General and administrative expense

3.3m4.7m4.9m

Operating expense total

4.0m5.5m6.7m

EBIT

(3.9m)(5.3m)(6.1m)

EBIT margin, %

(2798%)(1208%)(652%)

Interest expense

1.1m23.7k2.3k

Net Income

(5.7m)(5.3m)(7.8m)

Guardion Health Sciences Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018

Cash

62.5k4.7m670.9k

Accounts Receivable

1.7k72.8k28.2k

Prepaid Expenses

29.4k117.2k47.8k

Inventories

44.0k154.7k358.0k

Current Assets

137.6k5.1m1.1m

PP&E

114.0k95.6k274.8k

Goodwill

1.6m1.6m

Total Assets

262.0k7.4m3.7m

Accounts Payable

356.5k311.2k413.9k

Short-term debt

14.0k30.5k

Current Liabilities

607.6k499.9k495.3k

Total Debt

14.0k30.5k

Total Liabilities

607.6k

Common Stock

25.0k40.2k20.6k

Preferred Stock

1.7k

Additional Paid-in Capital

20.3m33.7m37.8m

Retained Earnings

(20.7m)(26.9m)(34.6m)

Total Equity

345.6k7.4m3.7m

Debt to Equity Ratio

0 x0 x

Debt to Assets Ratio

0.1 x0 x

Financial Leverage

0.8 x1 x1 x

Guardion Health Sciences Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018

Net Income

(5.7m)(5.3m)(7.8m)

Depreciation and Amortization

60.1k118.8k295.7k

Accounts Receivable

(537.0)(21.0k)44.6k

Inventories

(13.4k)(17.4k)(203.3k)

Accounts Payable

84.6k(121.9k)102.7k

Cash From Operating Activities

(1.7m)(3.4m)(4.2m)

Purchases of PP&E

(3.4k)(37.3k)(260.2k)

Cash From Investing Activities

(3.4k)(32.4k)(310.2k)

Short-term Borrowings

(1.9k)(30.5k)

Long-term Borrowings

(151.0k)(149.0k)

Cash From Financing Activities

1.7m8.1m419.8k

Net Change in Cash

48.7k4.7m(4.1m)

Interest Paid

23.5k

Guardion Health Sciences Ratios

USDY, 2019

EV/EBIT

-8.4 x

EV/CFO

-4.8 x

Financial Leverage

1.1 x